BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 9644632)

  • 1. Mineralized bone loss at different sites in dialysis patients: implications for prevention.
    Schober HC; Han ZH; Foldes AJ; Shih MS; Rao DS; Balena R; Parfitt AM
    J Am Soc Nephrol; 1998 Jul; 9(7):1225-33. PubMed ID: 9644632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Azotaemic renal osteodystrophy: a quantitative study on iliac bone.
    Ellis HA; Peart KM
    J Clin Pathol; 1973 Feb; 26(2):83-101. PubMed ID: 4696838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Irreversible bone loss in osteomalacia. Comparison of radial photon absorptiometry with iliac bone histomorphometry during treatment.
    Parfitt AM; Rao DS; Stanciu J; Villanueva AR; Kleerekoper M; Frame B
    J Clin Invest; 1985 Dec; 76(6):2403-12. PubMed ID: 4077986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteomalacia in patients with chronic renal failure before dialysis or transplantation.
    Mora Palma FJ; Ellis HA; Cook DB; Dewar JH; Ward MK; Wilkinson R; Kerr DN
    Q J Med; 1983; 52(207):332-48. PubMed ID: 6647748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Periosteal new bone formation (periosteal neostosis) in renal osteodystrophy. Relationship to osteosclerosis, osteitis fibrosa, and osteoid excess.
    Meema HE; Oreopoulos DG; Rabinovich S; Husdan H; Rapoport A
    Radiology; 1974 Mar; 110(3):513-22. PubMed ID: 4204516
    [No Abstract]   [Full Text] [Related]  

  • 6. [Etiology and pathology of metabolic bone diseases: renal osteodystrophy].
    Shigematsu T; Ogura Y
    Nihon Rinsho; 1986 Nov; 44(11):2428-36. PubMed ID: 3546796
    [No Abstract]   [Full Text] [Related]  

  • 7. Iliac bone marrow mast cells in relation to the renal osteodystrophy of patients treated by haemodialysis.
    Ellis HA; Peart KM
    J Clin Pathol; 1976 Jun; 29(6):502-16. PubMed ID: 939806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone aluminum and histomorphometric features of renal osteodystrophy.
    Hodsman AB; Sherrard DJ; Alfrey AC; Ott S; Brickman AS; Miller NL; Maloney NA; Coburn JW
    J Clin Endocrinol Metab; 1982 Mar; 54(3):539-46. PubMed ID: 7056841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical spectrum of renal osteodystrophy in 57 chronic hemodialysis patients: a correlation between biochemical parameters and bone pathology findings.
    Chazan JA; Libbey NP; London MR; Pono L; Abuelo JG
    Clin Nephrol; 1991 Feb; 35(2):78-85. PubMed ID: 2019018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal osteodystrophy--pathogenesis and treatment.
    Cushner HM; Adams ND
    Am J Med Sci; 1985 Dec; 290(6):234-45. PubMed ID: 3909812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review: Renal osteodystrophy--pathogenesis and treatment.
    Cushner HM; Adams ND
    Am J Med Sci; 1986 Apr; 291(4):264-75. PubMed ID: 3518448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Histomorphometric study of bone tissue in chronic renal failure].
    Kontek M
    Pol Arch Med Wewn; 1980 Apr; 63(4):363-73. PubMed ID: 7413466
    [No Abstract]   [Full Text] [Related]  

  • 13. Renal osteodystrophy in CAPD.
    Hutchison AJ; Freemont AJ; Lumb GA; Gokal R
    Adv Perit Dial; 1991; 7():237-9. PubMed ID: 1680434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of minimodeling in dialysis patients with adynamic bone disease.
    Ubara Y; Tagami T; Nakanishi S; Sawa N; Hoshino J; Suwabe T; Katori H; Takemoto F; Hara S; Takaichi K
    Kidney Int; 2005 Aug; 68(2):833-9. PubMed ID: 16014063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A study using nondecalcified bone biopsy of the incidence and presentation forms of renal osteodystrophy].
    Lorenzo Sellares V; Torres Ramírez A; Hernández Marrero D; Rodríguez Pérez J; González Posada J; Losada Cabrera M; Maceira Cruz B; Hernández Nieto L
    Med Clin (Barc); 1991 Apr; 96(15):561-5. PubMed ID: 2051811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodialysis bone disease: correlation between clinical, histologic, and other findings.
    Alvarez-Ude F; Feest TG; Ward MK; Pierides AM; Ellis HA; Peart M; Simpson W; Weightman D; Kerr DN
    Kidney Int; 1978 Jul; 14(1):68-73. PubMed ID: 682426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of haemodialysis on bone in chronic renal failure.
    Bishop MC; Woods CG; Oliver DO; Ledingham JG; Smith R; Tibbutt DA
    Br Med J; 1972 Sep; 3(5828):664-7. PubMed ID: 4650845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved radiological diagnosis of azotemic osteodystrophy.
    Meema HE; Rabinovich S; Meema S; Lloyd GJ; Oreopoulos DG
    Radiology; 1972 Jan; 102(1):1-10. PubMed ID: 5008148
    [No Abstract]   [Full Text] [Related]  

  • 19. Value of the 99mTc-methylene diphosphonate bone scan in renal osteodystrophy.
    Karsenty G; Vigneron N; Jorgetti V; Fauchet M; Zingraff J; Drüeke T; Cournot-Witmer G
    Kidney Int; 1986 May; 29(5):1058-65. PubMed ID: 3723927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated bone aluminum content in dialysis patients without osteomalacia.
    McCarthy JT; Kurtz SB; McCall JT
    Mayo Clin Proc; 1985 May; 60(5):315-20. PubMed ID: 3990380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.